Asbestos News Daily
MESOTHELIOMA SCREENING

 
     
  Friday, December 15th, 2017 MESOTHELIOMA SCREENING
 
 
 
 

ASBESTOSNEWSDAILY.COM NEWS ARCHIVES
AsbestosNewsDaily.com

HOME
MESOTHELIOMA IN THE NEWS
ASBESTOS IN THE NEWS
MESOTHELIOMA WORLD HEADLINES
ASBESTOS IN YOUR NEIGHBORHOOD
ASBESTOS IN THE WORKPLACE
ASBESTOS FACTS AND STATISTICS
SECONDHAND EXPOSURE
MESOTHELIOMA SYMPTOMS
MESOTHELIOMA TREATMENTS
MESOTHELIOMA DIAGNOSIS
MESOTHELIOMA DOCTORS
MESOTHELIOMA SCREENING
MESOTHELIOMA STAGES
MESOTHELIOMA DRUGS
MESOTHELIOMA NUTRITION
MESOTHELIOMA RESEARCH
MESOTHELIOMA CLINICAL TRIALS
MESOTHELIOMA CANCER CENTERS
MESOTHELIOMA BOOK REVIEWS
PLEURAL MESOTHELIOMA
PERICARDIAL MESOTHELIOMA
PERITONEAL MESOTHELIOMA
ASBESTOS RELATED CANCERS
ASBESTOS NAVY VETERANS
ASBESTOS CONTRACTOR FINES
ASBESTOS LEGISLATION
ASBESTOS PRODUCTS LIST
ASBESTOS TRADES LIST
ASBESTOS ALERTS!
MESOTHELIOMA AWARENESS & GRANTS
MESOTHELIOMA COURT VERDICTS
MESOTHELIOMA WRONGFUL DEATH
MESOTHELIOMA LEGAL HISTORY
MESOTHELIOMA LAWYERS
ASBESTOS ODDLY ENOUGH
MESOTHELIOMA LAWSUITS
ALUMINUM PLANTS
CHEMICAL PLANTS
STEEL MILLS
OIL REFINERIES
POWER PLANTS
SHIPYARDS
ASBESTOS COMPANIES
ASBESTOS CITIES
ASBESTOS JOBSITES
ASBESTOS NAVY SHIPS
WOMEN AND MESOTHELIOMA


AsbestosNewsDaily.com

ABOUT US
CONTACT US
PRIVACY POLICY
ASBESTOS BANKRUPTCY CLAIMS
ASBESTOS BANKRUPTCY TRUSTS

MESOTHELIOMA LAWYER BY STATES
AsbestosNewsDaily.com

HOME
ALABAMA MESOTHELIOMA LAWYER
ALASKA MESOTHELIOMA LAWYER
ARIZONA MESOTHELIOMA LAWYER
ARKANSAS MESOTHELIOMA LAWYER
CALIFORNIA MESOTHELIOMA LAWYER
COLORADO MESOTHELIOMA LAWYER
CONNECTICUT MESOTHELIOMA LAWYER
DELAWARE MESOTHELIOMA LAWYER
FLORIDA MESOTHELIOMA LAWYER
GEORGIA MESOTHELIOMA LAWYER
HAWAII MESOTHELIOMA LAWYER
IDAHO MESOTHELIOMA LAWYER
ILLINOIS MESOTHELIOMA LAWYER
INDIANA MESOTHELIOMA LAWYER
IOWA MESOTHELIOMA LAWYER
KANSAS MESOTHELIOMA LAWYER
KENTUCKY MESOTHELIOMA LAWYER
LOUISIANA MESOTHELIOMA LAWYER
MAINE MESOTHELIOMA LAWYER
MARYLAND MESOTHELIOMA LAWYER
MASSACHUSETTS MESOTHELIOMA LAWYER
MICHIGAN MESOTHELIOMA LAWYER
MINNESOTA MESOTHELIOMA LAWYER
MISSISSIPPI MESOTHELIOMA LAWYER
MISSOURI MESOTHELIOMA LAWYER
MONTANA MESOTHELIOMA LAWYER
NEBRASKA MESOTHELIOMA LAWYER
NEVADA MESOTHELIOMA LAWYER
NEW HAMPSHIRE MESOTHELIOMA LAWYER
NEW JERSEY MESOTHELIOMA LAWYER
NEW MEXICO MESOTHELIOMA LAWYER
NEW YORK MESOTHELIOMA LAWYER
NORTH CAROLINA MESOTHELIOMA LAWYER
NORTH DAKOTA MESOTHELIOMA LAWYER
OHIO MESOTHELIOMA LAWYER
OKLAHOMA MESOTHELIOMA LAWYER
OREGON MESOTHELIOMA LAWYER
PENNSYLVANIA MESOTHELIOMA LAWYER
RHODE ISLAND MESOTHELIOMA LAWYER
SOUTH CAROLINA MESOTHELIOMA LAWYER
SOUTH DAKOTA MESOTHELIOMA LAWYER
TENNESSEE MESOTHELIOMA LAWYER
TEXAS MESOTHELIOMA LAWYER
UTAH MESOTHELIOMA LAWYER
VERMONT MESOTHELIOMA LAWYER
VIRGINIA MESOTHELIOMA LAWYER
WASHINGTON MESOTHELIOMA LAWYER
WEST VIRGINIA MESOTHELIOMA LAWYER
WISCONSIN MESOTHELIOMA LAWYER
WYOMING MESOTHELIOMA LAWYER

Asbestos Mesothelioma Resource Links
AsbestosNewsDaily.com

MESO RESEARCH FOUNDATION
AMERICAN CANCER FOUNDATION
MESOTHELIOMAASBESTOSHELPCENTER.COM
CANCER.GOV - FACTSHEET/TYPES/MESOTHELIOMA
NATIONAL CANCER INSTITUTE - MESOTHELIOMA
CANCER.GOV - RADIATION THERAPY FORCANCER
CANCER.GOV- FACTSHEET/THERAPY/RADIATION
WIKIPEDIA: MESOTHELIOMA PAGE
EPA | INDOORAIR QUALITY | ASBESTOS
NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY -ASBESTOS
CALIFORNIAGEOLOGICAL SURVEY: ASBESTOS REPORTS -MAPS
ASBESTOS LEGISLATIVEHISTORY
NATIONAL CANCER SURVIVORS DAY FOUNDATION
WORLDCANCERCAMPAIGN.ORG
AMERICA’S ASBESTOS EPIDEMIC
CANCERCARE.ORG
WORLDCANCER DAY - FEBRAURY 04, 2010
NATIONALCANCER INSTITUTE
ASBESTOS DISEASE AWARENESS ORGANIZATION
EPA ASBESTOS HOME PAGE(Environmental Protection Agency)
ASBESTOS CONSTRUCTION HAZARD ALERT(Center to Protect Workers Rights)

 

ASBESTOS DAILY NEWS ADMINISTRATION
AsbestosNewsDaily.com

Report Broken Link
brokenlink@asbestosnewsdaily.com

Submit Asbestos Video
asbestosvideo@asbestosnewsdaily.com

Submit Asbestos Daily News Articles
asbestosnews@asbestosnewsdaily.com

Have a Question?
support@asbestosnewsdaily.com

Need a Lawyer?
needalawyer@asbestosnewsdaily.com

Need a Doctor?
needadoctor@asbestosnewsdaily.com

HONOR OF THE FALLEN SOLDIERS


 UGANDABUYAMBA.COM ORPHAN OUTREACH

 
 
 
 
 
ASBESTOS NEWS DAILY - MESOTHELIOMA SCREENING
AsbestosNewsDaily.com
 
4 Related Articles 
 

Mesothelioma Screening


 

 
Share this: facebook twitter linkedin reddit stumble delicious mixx digg yahoo
 
 
 
 

Mesothelioma Screening - Imaging Scans

MR Imaging

In patients with potentially resectable disease, MR imaging can provide additional staging information. Use of different pulse sequences and gadolinium-based contrast material can help differentiate between tumor and normal tissue. Relative to adjacent chest wall muscle, MPM is typically iso- or slightly hyperintense on T1-weighted images and moderately hyperintense on T2-weighted images. MPM enhances with use of gadolinium-based contrast material. The excellent contrast resolution of MR imaging can allow improved detection of tumor extension, especially to the chest wall and diaphragm, and better prediction of overall resectability. Anatomic and morphologic MR imaging features similar to those seen at CT are used to establish local invasion of MPM. Loss of normal fat planes, extension into mediastinal fat, and tumoral encasement of more than 50% of the circumference of a

medi-astinal structure are some of the MR imaging features that suggest tumor extension.

A recent study showed that MR imaging is superior to CT in revealing two types of invasive growth of MPM: invasion of the diaphragm and invasion of endothoracic fascia or a single chest wall focus . MR imaging is most useful in evaluating patients with questionable areas of local tumor extension at CT or in whom intravenous administration of iodinated contrast material is contraindicated.

Imaging Tests

Chest x-ray: This may show irregular thickening of the pleura, calcium deposits on the pleura, or fluid in the pleural space. These findings suggest asbestos exposure leading to the development of a mesothelioma.

Imaging studies such as x-rays, computed tomography (CT) scans, and magnetic resonance imaging (MRI) scans will help determine the location, size, and extent of the cancer.

Computed tomography (CT): The CT scan is an X-ray procedure that produces detailed cross-sectional images of your body. Instead of taking one picture, like a conventional x-ray, a CT scanner takes many pictures as it rotates around you. A computer then combines these pictures into an image of a slice of your body. The machine will take pictures of multiple slices of the part of your body that is being studied.

CT scans are often used to make the initial diagnosis of malignant mesothelioma, and are helpful in staging the cancer (determining the extent of its spread).

Often after the first set of pictures is taken you will receive an intravenous injection of a "dye" or radiocontrast agent that helps better outline structures in your body. A second set of pictures is then taken. CT scans are more tiring than regular x-rays because they take longer and you need to lie still on a table while they are being done. But just like other computerized devices, they are getting faster and your stay might be pleasantly short. Also, you might feel a bit confined by the ring you lie within when the pictures are being taken. You will have an IV (intravenous) line through which the contrast "dye" is injected. The injection can also cause some flushing (redness and warm feeling).

Some people are allergic and get hives or rarely more serious reactions like trouble breathing and low blood pressure. Be sure to tell the doctor if you have ever had a reaction to any contrast material used for x-rays. You may be asked to drink 1 to 2 pints of a solution of contrast material. This helps outline the intestine so that it is not mistaken for tumors.

Detecting Mesothelioma Using CAT / CT Scan

CT / CAT (computed axial tomography) scans are basically three dimensional x-rays that are able to project extremely detailed internal pictures of the organs, bones and skeletal structures. CT scan is a method of combining images from multiple x-rays using a computer to reproduce cross sectional or three-dimensional pictures of internal organs. It is useful in determining the location and spread of mesothelioma. They are much more accurate in detail than the x-ray, helping the physician / surgeon make a more accurate diagnosis. One of the drawbacks of CT scans is that it cannot differentiate between benign or malignant mesothelioma.

Positron Emission Tomography (PET Scan): In this test, radioactive glucose (sugar) is injected into your vein. Because cancers use sugar much faster than normal tissues, the cancerous tissue takes up the radioactive material. A scanner can spot the radioactive deposits. This test, which is still being
studied, is useful for telling whether a thickening of the tissues is cancer or merely scar tissue. It can also spot spread of the cancer.

Detecting Mesothelioma Using PET Scans

PET imaging is the best and most widely used imaging technology for diagnosing mesothelioma. PET scans use cameras and tracers that form images to indicate biological changes which are able to detect extremely small cancerous tumors. They are much superior in their image quality and details when compared to x-rays, CAT scans, and even MRI scans. PET scans also help the physician / surgeon in determining the staging of the cancer.

Magnetic resonance imaging (MRI): MRI scans use radio waves and strong magnets instead of x-rays. The energy from the radio waves is absorbed and then released in a pattern formed by the type of tissue and by certain diseases. A computer translates the pattern of radio waves given off by the tissues into a very detailed image of parts of the body. Not only does this produce cross sectional slices of the body like a CT scanner, it can also produce slices that are parallel with the length of your body. A contrast material might be injected just as with CT scans, but is used less often. Sometimes MRI scans are
useful in looking at the diaphragm (the thin muscle at the bottom of the lung cage that is responsible for breathing) where the mesothelioma may spread.

MRI scans are particularly helpful in examining the brain and spinal cord. MRI scans are a little more uncomfortable than CT scans. First, they take
longer - often up to 1 hour. Also, you have to be placed inside a tube, which is confining and can upset people with claustrophobia (fear of enclosed places). The machine also makes a thumping noise that you may find disturbing. Some places will provide headphones with music to block this out.

Detecting Mesothelioma Using MRI Scan

MRI scans are more sophisticated than the x-ray and CT scans. It makes use of high magnetic fields and radio waves, and with the help of a computer give physicians / surgeons a clear picture of the internal organs and skeletal structure. MRI scans are extremely clear and very useful in detecting mesothelioma related soft tissue growths and determining the severity of the tumor.

Source:
http://radiographics.rsna.org
http://www.hindustanlink.com
http://www.buzzle.com

http://mesotheliomaasbestoshelpcenter.com/mesothelioma-treatments/imaging-scans.html

 
Share this: facebook twitter linkedin reddit stumble delicious mixx digg yahoo
 
 

Dynamic Imaging Improves Patient Outcomes in Mesothelioma and Lung Cancer Treatment

Friday, November 27, 2009

Pinpointing the exact location of a lung cancer tumor and the extent of pleural effusion in mesothelioma is difficult with the traditional imaging techniques such as CT and MRI. Lung cancer tumors move with breathing, circulation and heartbeats making it difficult to focus radiation treatments and to evaluate the extent of disease.

Recent advances in imaging technologies, however, have improved how patients receive their radiation treatments. Dynamic imaging allows the medical staff to monitor the tumor movement throughout the respiratory cycle improving the quality of radiation therapy resulting in better patient outcomes.

Additional improvements include fusion technology where images from different imaging techniques can be combined, and online imaging offering images in the same room where radiation is given to more accurately guide the radiation therapy.

These improvements have led to non-invasive techniques which allow for the characterization of the aggressiveness of the tumors helping the medical
specialists better identify the therapy regimens or experimental clinical trials appropriate for malignant pleural mesothelioma patients.

Sources:
Chest Journal Study
National Lung Cancer Partnership

 

http://www.mesotheliomahelp.net/blog/2009/11/dynamic-imaging-improves-patient.asp

 
Share this: facebook twitter linkedin reddit stumble delicious mixx digg yahoo
 
 

Mesothelioma and Early Lung Cancer Identified by Screening

Posted on Tuesday, May 26, 2009.

ct mesothelioma scanUsing computed tomography scans to screen former asbestos workers can detect both early and late-stage lung cancer and late-stage mesothelioma, according to a study in the May Journal of Thoracic Oncology. However, it’s still not clear whether screening for these cancers might improve patients’ prognoses.

Exposure to asbestos fibers is a known risk factor for lung cancer and the cause of mesothelioma. Although asbestos is still not completely banned in theU.S., it was phased out of American industry to a large degree beginning in the 1970s.  However because asbestos-related diseases can take 20 to 40 years to emerge after people have been exposed, former asbestos workers and those exposed to products containing this carcinogen continue to be diagnosed with asbestos caused cancers.

As researchers search for better treatments and even a cure for these diseases, they are also focusing on new diagnostic methods that might identify the cancers earlier. Early diagnosis is particularly crucial with mesothelioma, because many patients survive only one year after they first start to show signs, and symptoms are often difficult to distinguish from those of other lung diseases.

One potential screening method uses low-dose computed tomography (LDCT) to evaluate the lungs and their lining (pleura). LDCT can locate plaques in the lungs, which are a sign of asbestos exposure and have been linked to an increased cancer risk.

Currently, there are no recommendations about using LDCT or any other method to screen people who have been exposed to asbestos, and screening isn’t routinely done. “There are currently no methods for the early detection of mesothelioma available,” says lead author Heidi Roberts, MD, Associate Professor of Radiology at theUniversity ofToronto.  “This is why we are doing the research.”

To determine the effectiveness of LDCT as a screening tool for asbestos-related lung cancers, Dr. Roberts and her colleagues recruited 516 people (most of them men) who had been exposed to asbestos at least 20 years before, or who had known plaques. Participants were given LDCT scans of the chest. Patients who had abnormal scans were given follow-up tests. Those with normal test results were invited to have an annual LDCT scan.

Of the 516 participants, 357 had evidence of plaques. Based on the results of the first scan and annual scans, six of the patients were diagnosed with lung cancers and four were diagnosed with mesothelioma.

Although LDCT was able to detect advanced mesothelioma, as well as early- and late-stage lung cancers, it was not able to diagnose early mesothelioma. The study authors say they need to continue screening patients to help them get a better idea of what early mesothelioma looks like. Also, they say adding biomarkers (substances in the blood that indicate the presence of cancer) to the screening process may provide greater sensitivity to help diagnose those at very high risk for mesothelioma.

Even as techniques are fine-tuned, screening is just one step of a three-tiered effort to combat these cancers, according to Dr. Roberts. “The second step is the parallel development of biomarkers, and the third step is the parallel development of treatment strategies,” she says. “These have to be developed hand-in-hand in order to make this a useful and meaningful tool.”
 
Source:

Roberts HC, Patsios DA, Paul NS, dePerrot M, Teel W, Bayanati H, Shepherd F, Johnston MR. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure. Journal of Thoracic Oncology. 2009;5:620-628.

 

http://www.survivingmesothelioma.com/news/view.asp?ID=0032

 
Share this: facebook twitter linkedin reddit stumble delicious mixx digg yahoo
 
 

Prometheus announces new mesothelioma diaPrometheus Launches ProOnc Dx Cancer Diagnostics

Thu Oct 15, 2009 7:00am EDT

 

Three New Tests Based on Breakthrough MicroRNA Technology
 
SAN DIEGO, Oct. 15 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty
pharmaceutical and diagnostic company, today announced the nationwide
commercial launch of three new cancer diagnostic products: ProOnc TumorSource
Dx, ProOnc Squamous Dx and ProOnc Mesothelioma Dx. Each of these tests is
based on recently developed, highly sensitive microRNA technology.
 
"Prometheus has a long and successful history of providing innovative
diagnostics that complement targeted therapeutics to help physicians
individualize patient care," said Joseph M. Limber, President and Chief
Executive Officer of Prometheus. "Now we are proud to introduce the first
three products from our cancer diagnostics portfolio with the launch of ProOnc
Dx. We believe that these highly tissue-specific tests provide more objective
and quantitative results than current methods, which, may lead to more
personalized treatments for patients."
 
ProOnc TumorSource Dx identifies the tissue-of-origin of a metastatic tumor.
The test identifies 25 different tumor types, including colon, liver, brain,
breast, kidney, lung, ovary, pancreas, prostate and testis, and measures the
expression level of 48 microRNA biomarkers. ProOnc TumorSource Dx uses a
proprietary classifier to assign a primary site to the cancer sample based on
the microRNA expression in the tumor and may become a critical tool in the
detection of cancer of unknown primary (CUP).
 
ProOnc Squamous Dx classifies non-small cell lung carcinoma tumors into two
histological groups: cancers of squamous histology and non-squamous cancers.
The test measures the expression level of a squamous microRNA biomarker to
differentiate patients that have squamous cell carcinoma of the lung from
patients that have non-squamous non-small cell lung cancer.
 
ProOnc Mesothelioma Dx is a cutting-edge molecular diagnostic test that uses
microRNA to differentiate malignant pleural mesothelioma from peripheral
adenocarcinoma of the lung and metastatic carcinomas involving the lung and
pleura.
 
"MicroRNAs are small, non-coding sequences of RNA that are critically
important in many biological and pathological processes," saidHarveyPass,
M.D., Professor of Cardiothoracic Surgery and Director of the Division of
Thoracic Surgery and Thoracic Oncology atNew YorkUniversity Langone Medical
Center and its NYU Cancer Institute. "The sensitivity and specificity of
microRNA-based diagnostics should enable clinicians to differentiate
particular cancer tissues with increased confidence, which may ultimately
guide medical oncologists to deliver the safest and most efficacious therapy
for their patients."
 
For more information about ProOnc Dx tests, please call (877) 378-4919 or
visit www.prometheusoncology.com.
 
Prometheus acquired exclusiveU.S. rights to ProOnc TumorSource Dx, ProOnc
Squamous Dx and ProOnc Mesothelioma Dx from Rosetta Genomics (Nasdaq: ROSG) in
April 2009. The tests are offered as miRview mets, miRview squamous and
miRview meso outside of theU.S. In addition, Prometheus and Rosetta are
collaborating to develop two new microRNA-based gastroenterology tests.
 
About Prometheus
 
Prometheus Laboratories Inc. is a specialty pharmaceutical and diagnostic
company committed to developing and commercializing novel pharmaceutical and
diagnostic products to help physicians individualize patient care. Prometheus
is a leader in applying the principles of personalized medicine to the
diagnosis and treatment of gastrointestinal diseases and is applying these
principles to oncology. Its strategy includes the marketing and delivery of
pharmaceutical products complemented by proprietary diagnostic testing
services. By integrating pharmaceutical products and diagnostic testing
services, Prometheus believes it can address the full continuum of care,
thereby providing physicians with a comprehensive solution to treat chronic
diseases. Prometheus' corporate offices are located inSan Diego.
 
ProOnc TumorSource Dx, ProOnc Squamous Dx and ProOnc Mesothelioma Dx are
trademarks of Prometheus Laboratories Inc. miRview mets, miRview squamous and
miRview meso are trademarks of Rosetta Genomics Ltd.
OURCE Prometheus Laboratories Inc.
 
Pete DeSpain, Director, Investor Relations & Corporate Communications of
Prometheus Laboratories Inc., +1-858-587-4117, pdespain@prometheuslabs.com; or
John F. Kouten, Chief Executive Officer of JFK Communications, Inc.,
+1-609-514-5117, jfkouten@jfkhealth.com, for Prometheus Laboratories Inc.
 

http://www.reuters.com/article/idUS99836+15-Oct-2009+PRN20091015

 
Share this: facebook twitter linkedin reddit stumble delicious mixx digg yahoo
 
 
 
 
 
 
 
35 Related Videos
 
Pleural Mesothelioma: a foreseable and avoidable death
10:01

Pleural Mesothelioma: a foreseable and avoidabledeath

Epidemiologic observations on an anatomical-pathologic and clinic case study from 1997 to 2006 - Service of Preventive Medicine (Head: Dr. Gerardo...

 
 
My Wife Was Murdered
8:45

My Wife Was Murdered

Wife died of Mesothelioma

 
 
Spodden Valley, asbestos scandal (part 1)
9:55

Spodden Valley, asbestos scandal (part 1)

Rochdale,North westEngland 1982. A scandalous company cover up in a site that processed Canadian chrysotile asbestos from the 1870s thru to the...

 
Canada blocks asbestos banAdded to
4:54

Canada blocksasbestos ban

More at therealnews.com UN Rotterdam treaty on toxic trade restrictions marred byCanada's stance onasbestos

 
Asbestos in building construction 1959
2:26

Asbestos in building construction 1959

This was clipped from the 1959 film,Asbestos a matter of time, by the US Bureau of Mines, Department of the Interior.

 
 
 
 
MP: "Fireproof Cotton Rock" - Asbestos in China Found by Marco PoloAdded to
2:22

MP: "Fireproof Cotton Rock" -Asbestos in China Found by Marco Polo

MARCO POLO: THECHINA MYSTERY REVEALED Did Marco Polo Really Discover Asbestos?

 
 
 
 
 
1965 Armstong asbestos tile commercial
1:16

1965 Armstongasbestos tile commercial

n 1860, Thomas M. Armstrong, the son of Scotish-Irish immigrants from Londonderry, joined with John D. Glass to open a one-room shop in Pittsburgh...

 
 
Asbestos in electrical work 1959
0:58

Asbestos in electrical work 1959

This was clipped from the 1959 film, Asbestos a matter of time, by the US Bureau of Mines, Department of the Interior. For more information about...

 
Asbestos The Silent Killer Part 1 of 3
8:45

Asbestos The Silent Killer Part 1 of 3

Produced by United Steelworkers Local 480 at the Teck Cominco Smelter in Trail, BC, this hard-hitting documentary examines the devastating human...

 
 
Asbestos Tragedy Libby Montana 2004 USEPA
2:36

Asbestos Tragedy Libby Montana 2004 USEPA

Processed vermiculite from the WR Grace Libby MT Mine contained tremolite, a form of asbestos, that was allowed to contaminate local

 
 
Summerlin Rd, Asbestos found, Fox News.wmv
2:10

Summerlin Rd,Asbestos found, FoxNews.wmv

Summerlin Rdasbestos found. Reported by FoxNews..

 
 
 
 
 
 
Video: Old Promotional Film For AsbestosAdded to
Quicklist
3:45

Video: Old Promotional Film ForAsbestos

www.searchmesothelioma.net Both the government and corporate industry used promotional newsreel type films during the 1950s and 1960s to promote...

 
Introduction to Asbestos from 1959Added to
Quicklist
2:30

Introduction toAsbestos from 1959

This clip is from the 1959 film, "Asbestos: a Matter of Time," by the Bureau of Mines (US Department of the Interior.) The entire film is..

 
 
 
 


4:38

About theAsbestos DiseaseAwareness Organization (ADAO)
Asbestos DiseaseAwareness Organization, ADAO, Linda Reinstein, BanAsbestos, www.adao.us

 

8:31
mesothelioma
Mesothelioma is an incurableasbestos cancer. This short film was produced to raiseawareness of the issues around mesothelioma. It...

 

 
 
 
      Home | About Us | Contact Us | Privacy Policy      

Disclaimer:
Please Contact a physician with regard to health concerns.
The materials contained on this AsbestosNewsdaily.com are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.
Many links on Asbestosnewsdaily.com lead to other sites. AsbestosNewdaily.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is Asbestosnewsdaily.com responsible for dead or misdirected links.
IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT removenews@asbestosnewsdaily.com. We will do our best to accommodate your request.

    Copyright 2009 - 2017
All Rights Reserved. AsbestosNewsDaily.com
   
      Mesothelioma Lawyer